{"meta":{"query_hash":"62d4026bcfaa","filters":{"venue":"Therapeutic Advances in Respiratory Disease"},"cohort_total":44,"direct_labels_cover":0,"predictions_cover":44,"exported":44,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/62d4026bcfaa","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Respiratory+Disease"},"results":[{"id":"W1989313138","doi":"10.1177/1753465812468041","title":"Bronchoscopic staging of lung cancer","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bronchoscopy; Radiology; Lung cancer; Biopsy; Stage (stratigraphy); Endobronchial ultrasound; Sampling (signal processing); Pathology","score_opus":0.06566833208853237,"score_gpt":0.4428482138983636,"score_spread":0.3771798818098312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989313138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000953202,0.9973844,0.000015640448,0.000022138163,0.0004163019,0.0015285349,0.00012287045,0.00003578948,0.00037898085],"genre_scores_gemma":[0.001077257,0.9968413,0.00002484534,0.00038284727,0.00030944112,0.0011511415,0.000028549106,0.0000869957,0.00009759986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978814,0.000159577,0.0007172247,0.0004545309,0.00035499208,0.00043228082],"domain_scores_gemma":[0.9983707,0.00014733667,0.00042243107,0.00067752996,0.00005124526,0.00033073194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001597595,0.00046627666,0.0016905301,0.00025176574,0.000035041772,0.000008164702,0.00018225831,0.00012328007,0.00039703504],"category_scores_gemma":[0.000012288689,0.0003446411,0.0004033193,0.0003513103,0.0001312837,0.0001736981,0.000051932213,0.00028741203,0.000012644816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056174456,0.00037079735,0.029020252,0.059695307,0.00027804598,0.000034780987,0.000038088943,0.00000597817,1.11640695e-7,0.0001338741,0.000018726416,0.9103479],"study_design_scores_gemma":[0.00087108783,0.000060272585,0.0015405403,0.03562246,0.004931328,5.983672e-7,0.000007198531,0.0000024825015,0.0000018271664,0.00002780133,0.95666176,0.00027264902],"about_ca_topic_score_codex":0.0000111304025,"about_ca_topic_score_gemma":0.0000100399175,"teacher_disagreement_score":0.95664304,"about_ca_system_score_codex":0.0009155424,"about_ca_system_score_gemma":0.0010449569,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W2010869771","doi":"10.1177/1753465809336697","title":"The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; COPD; Placebo; Prednisone; Internal medicine; Fluticasone propionate; Gastroenterology; Fluticasone; Corticosteroid; Neopterin; Immunology; Pathology","score_opus":0.019171933048854287,"score_gpt":0.3350420072401586,"score_spread":0.3158700741913043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010869771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613105,0.0357627,0.0000039338415,0.00011547065,0.0001365562,0.00247853,0.000011409841,0.000046808465,0.00013409098],"genre_scores_gemma":[0.99824005,0.000677916,0.000006161009,0.00075211853,0.00005181327,0.00021144407,0.0000035801036,0.00003945639,0.000017453094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667376,0.00091721496,0.000603552,0.000595376,0.0006706932,0.00053941266],"domain_scores_gemma":[0.9979376,0.00046158346,0.00016122045,0.0008666752,0.0000811193,0.0004918047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068457675,0.00034339266,0.0004738414,0.00036840624,0.000123318,0.000027045531,0.00027974905,0.000072298426,0.000015073769],"category_scores_gemma":[0.00021533109,0.0002653935,0.00007738672,0.00050122524,0.00055391836,0.00046483957,0.000075844764,0.00037170318,0.000005397517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007080039,0.0027846568,0.5842242,0.0005808318,0.00009388288,0.0012683256,0.0007785814,0.000045534198,0.0013711824,0.00026463004,0.0000056408007,0.4015025],"study_design_scores_gemma":[0.007415261,0.0022077244,0.9849793,0.00033091623,0.00008982857,0.000002213175,0.001840975,0.00022492652,0.00028065333,0.0014504382,0.0009154909,0.00026228683],"about_ca_topic_score_codex":0.0000025004344,"about_ca_topic_score_gemma":0.00016262419,"teacher_disagreement_score":0.4012402,"about_ca_system_score_codex":0.0003092596,"about_ca_system_score_gemma":0.00040388803,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W2031291407","doi":"10.1177/1753465808088903","title":"Review: Surfactant protein D: A lung specific biomarker in COPD?","year":2008,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"Canada Research Chairs; Michael Smith Health Research BC","keywords":"Medicine; COPD; Biomarker; Pulmonary surfactant; Lung; Surfactant protein A; Intensive care medicine; Internal medicine; Chemical engineering; Biochemistry","score_opus":0.13246546096673179,"score_gpt":0.46302789878847844,"score_spread":0.33056243782174666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031291407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003647138,0.9870483,0.000012145969,0.00009970323,0.00018893868,0.011736924,0.0001296471,0.00010588564,0.00064197637],"genre_scores_gemma":[0.000017142422,0.99281645,0.00004835852,0.003521413,0.00014005975,0.0028666637,0.000079268306,0.00025772638,0.00025290166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912465,0.0017543313,0.002552175,0.0015941092,0.0013967725,0.0014560695],"domain_scores_gemma":[0.9953936,0.0005412434,0.0006759375,0.001996689,0.0001792937,0.0012132423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013062056,0.0011529678,0.0038924708,0.0013058399,0.00012004374,0.000025120866,0.0007793021,0.00041683874,0.0004980727],"category_scores_gemma":[0.00047964402,0.00093891856,0.00074746314,0.002601194,0.00055238826,0.0003825867,0.00020539618,0.0019930273,0.000360085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005807403,0.00039600875,0.00013635568,0.19115478,0.000043563523,0.0030152777,0.000009103356,5.490654e-7,0.0000030003503,0.000044389675,0.00041763915,0.80419856],"study_design_scores_gemma":[0.0014439702,0.00013248503,0.00021684763,0.15589648,0.00014310368,0.000028418688,0.0000045487864,0.000006491837,8.336387e-7,0.000042027707,0.8414364,0.00064841245],"about_ca_topic_score_codex":0.0000056699278,"about_ca_topic_score_gemma":0.000018250053,"teacher_disagreement_score":0.84101874,"about_ca_system_score_codex":0.0019045193,"about_ca_system_score_gemma":0.0049215853,"threshold_uncertainty_score":0.99930614},"labels":[],"label_agreement":null},{"id":"W2054659948","doi":"10.1177/1753465807082374","title":"Review: Systemic consequences of COPD","year":2007,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Medicine; COPD; Intensive care medicine; Systemic inflammation; Internal medicine; Inflammation","score_opus":0.08859215697106429,"score_gpt":0.4335139670867134,"score_spread":0.34492181011564915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054659948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023356606,0.9929282,0.00003134066,0.00003105014,0.00027530742,0.004770685,0.00039584655,0.000079541634,0.0014646769],"genre_scores_gemma":[0.00018090068,0.9971559,0.000029698283,0.0013335408,0.00023515211,0.00059436494,0.00011306401,0.00014032623,0.00021702124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398583,0.0008889478,0.0020982563,0.0010635998,0.0011183597,0.00084501086],"domain_scores_gemma":[0.99566936,0.0006267084,0.0009674926,0.0016154222,0.0003239383,0.000797063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011861846,0.0008555881,0.0037242393,0.0007660868,0.000070280104,0.000013150076,0.00073057745,0.00028518922,0.0004743129],"category_scores_gemma":[0.00034891363,0.00068431994,0.0009909617,0.0013970108,0.0015001133,0.0002486328,0.00015830788,0.0009134503,0.0001385719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016975576,0.00021629762,0.00038932238,0.33194384,0.00013058682,0.0005669136,0.0000068149766,0.0000014744865,0.0000020783252,0.0002982754,0.00009840984,0.66617626],"study_design_scores_gemma":[0.0006779527,0.00008368014,0.00013766879,0.2003987,0.001660513,0.00005624148,0.000034593126,0.0000018846123,0.000001892075,0.00020363447,0.7962953,0.00044798513],"about_ca_topic_score_codex":0.0000050123413,"about_ca_topic_score_gemma":0.0000028502614,"teacher_disagreement_score":0.7961968,"about_ca_system_score_codex":0.0010435507,"about_ca_system_score_gemma":0.0043283305,"threshold_uncertainty_score":0.9995608},"labels":[],"label_agreement":null},{"id":"W2061612454","doi":"10.1177/1753465810371107","title":"Emerging therapies in cystic fibrosis","year":2010,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Gilead Sciences","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Clinical trial; Life expectancy; Disease; Targeted therapy; Immunology; Intensive care medicine; Bioinformatics; Internal medicine; Population","score_opus":0.04226880032122836,"score_gpt":0.4069944207173359,"score_spread":0.3647256203961075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061612454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001539337,0.99623555,0.00008786439,0.000054962515,0.00036620698,0.002437767,0.000115189265,0.00012070941,0.00042779153],"genre_scores_gemma":[0.0002802599,0.9962359,0.00063274277,0.00033829507,0.0003233675,0.0017569816,0.00007115332,0.000199831,0.00016143928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481064,0.0006217575,0.0014258435,0.0011422058,0.0009147796,0.0010847817],"domain_scores_gemma":[0.9964627,0.0010533208,0.0004148145,0.0013648858,0.00009363083,0.00061064353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007523863,0.00092147937,0.0026215257,0.0013086557,0.0000989749,0.000061633815,0.0006550363,0.00036319534,0.00045679507],"category_scores_gemma":[0.00065635215,0.00073972356,0.00059181126,0.001471679,0.0005480634,0.00047906698,0.00016342982,0.0019159232,0.00014162663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004101637,0.00031135906,0.0011183684,0.018680494,0.00005014252,0.0003876712,0.00006359919,0.000014932434,0.000011731947,0.00020279235,0.000010285291,0.9787385],"study_design_scores_gemma":[0.0011330817,0.00018262048,0.00067903637,0.021136792,0.0003632173,0.000009159848,0.00005950409,0.00002170153,0.0000022627146,0.0012544562,0.9745064,0.0006517768],"about_ca_topic_score_codex":0.000005426697,"about_ca_topic_score_gemma":0.00006689899,"teacher_disagreement_score":0.9780867,"about_ca_system_score_codex":0.0004938975,"about_ca_system_score_gemma":0.0013515158,"threshold_uncertainty_score":0.9995054},"labels":[],"label_agreement":null},{"id":"W2097297828","doi":"10.1177/1753465811398720","title":"Management of fungal lung disease in the immunocompromised","year":2011,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Calgary","funders":"","keywords":"Medicine; Intensive care medicine; Fungal disease; Population; Antifungal; Disease; Lung; Immunology; Dermatology; Internal medicine; Environmental health","score_opus":0.06692709555202371,"score_gpt":0.3908724126531313,"score_spread":0.3239453171011076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097297828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006857903,0.9941835,0.00003779834,0.000015326204,0.00011358595,0.003242064,0.00006761386,0.000027202428,0.0016271214],"genre_scores_gemma":[0.022980783,0.97577137,0.000025918966,0.00028502115,0.00006029377,0.0006326761,0.000034933688,0.000057216148,0.0001518091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965851,0.0006341631,0.0011481981,0.00066962384,0.0004971107,0.0004658224],"domain_scores_gemma":[0.9975697,0.00019157627,0.0003908234,0.0015519584,0.000050350118,0.00024562728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007982794,0.00053463766,0.0014993914,0.00026463694,0.000055953657,0.000012973185,0.0006693325,0.00012086945,0.00015449447],"category_scores_gemma":[0.00003628226,0.00034647604,0.0006380147,0.0006520969,0.00036655448,0.0001661704,0.00009403325,0.00055710645,0.000023177941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016596272,0.0009802618,0.011023809,0.06218907,0.00014954456,0.0010194299,0.00009703123,0.0000030096248,2.771101e-7,0.002662137,0.0000096337835,0.9202062],"study_design_scores_gemma":[0.0016165035,0.00008803885,0.043926653,0.026072446,0.0022507666,0.0000011768673,0.00016266703,0.00001283735,2.7956128e-7,0.0013068052,0.9240893,0.00047254076],"about_ca_topic_score_codex":0.0000030733954,"about_ca_topic_score_gemma":0.000005784521,"teacher_disagreement_score":0.92407966,"about_ca_system_score_codex":0.00021662274,"about_ca_system_score_gemma":0.00052688504,"threshold_uncertainty_score":0.99989873},"labels":[],"label_agreement":null},{"id":"W2102177981","doi":"10.1177/1753465812470018","title":"Indacaterol 75 µg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective","year":2013,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Public Health Agency of Canada; Novartis Pharmaceuticals Corporation; AstraZeneca","keywords":"Indacaterol; Medicine; COPD; Tolerability; Placebo; Bronchodilator; Salmeterol; Internal medicine; Confidence interval; Minimal clinically important difference; Adverse effect; Randomized controlled trial; Anesthesia; Asthma","score_opus":0.035162045052041686,"score_gpt":0.3586399126017456,"score_spread":0.3234778675497039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102177981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011389065,0.97281224,0.00007493169,0.000043083874,0.0001396685,0.012971558,0.0024594984,0.00005809178,0.00005186407],"genre_scores_gemma":[0.024831597,0.9645878,0.000052416257,0.00011983018,0.00042237117,0.009124323,0.00045232289,0.00025605602,0.00015329063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99488753,0.00047618448,0.0010654329,0.001493329,0.0010567798,0.0010207561],"domain_scores_gemma":[0.99481326,0.00084181,0.001057493,0.0017581389,0.00064582756,0.0008834813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012218002,0.0011806365,0.0024149541,0.0004761767,0.00023697174,0.000038640446,0.00070409646,0.00010517764,0.000103059865],"category_scores_gemma":[0.00008944981,0.0007089086,0.00087293313,0.0011856344,0.0021248828,0.0003996838,0.00011024215,0.00049622287,0.000022497563],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031691666,0.0021467526,0.07522267,0.010196913,0.00078980514,0.00011115385,0.00015119459,0.00007967471,1.3354307e-7,0.000082692786,0.0000035964147,0.90804625],"study_design_scores_gemma":[0.0026958662,0.0013338523,0.41643906,0.0023488377,0.003626573,0.0000015360245,0.0002875924,0.000089373956,4.851081e-7,0.00013869091,0.5723656,0.00067258533],"about_ca_topic_score_codex":0.00004815772,"about_ca_topic_score_gemma":0.00005487253,"teacher_disagreement_score":0.90737367,"about_ca_system_score_codex":0.0048894277,"about_ca_system_score_gemma":0.0031764193,"threshold_uncertainty_score":0.9995362},"labels":[],"label_agreement":null},{"id":"W2112801723","doi":"10.1177/1753465810382818","title":"The impact of psychological distress on exacerbation rates in COPD","year":2010,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Anxiety; Exacerbation; PsycINFO; COPD; Depression (economics); MEDLINE; Distress; Clinical psychology; Psychological distress; Intensive care medicine; Psychiatry; Internal medicine","score_opus":0.07204406549823535,"score_gpt":0.46507652019428997,"score_spread":0.39303245469605463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112801723","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008990001,0.9869646,0.0000043827276,0.000029827266,0.00018982857,0.0025051492,0.00027703695,0.000031586354,0.0010076034],"genre_scores_gemma":[0.023002312,0.9757682,0.000005673357,0.00007726784,0.00019682599,0.0006268647,0.00011722652,0.00008544438,0.00012018868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591357,0.0008752149,0.00105358,0.0008068407,0.0006899779,0.00066082773],"domain_scores_gemma":[0.99657667,0.0010646147,0.00048446996,0.0013337453,0.00011020839,0.00043030965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006177577,0.0006304839,0.0015115268,0.00039929856,0.00009922415,0.000031930038,0.00061323075,0.00031595668,0.00022581332],"category_scores_gemma":[0.00033367967,0.00036592694,0.000723343,0.00077514636,0.0009120243,0.00016491496,0.00009725093,0.0014456026,0.000044992375],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013479758,0.0010195881,0.0056309523,0.004641964,0.000060978706,0.0001821184,0.000013174276,0.00004218844,0.0000033351807,0.00038684113,0.0000233878,0.9866475],"study_design_scores_gemma":[0.0027950602,0.0006881073,0.159756,0.010691842,0.00037969014,0.000007864949,0.00005054333,0.00009525002,0.0000023347177,0.0021471481,0.82273674,0.0006494145],"about_ca_topic_score_codex":0.0000073474425,"about_ca_topic_score_gemma":0.000021896942,"teacher_disagreement_score":0.9859981,"about_ca_system_score_codex":0.0008528923,"about_ca_system_score_gemma":0.00081193727,"threshold_uncertainty_score":0.99987924},"labels":[],"label_agreement":null},{"id":"W2116275531","doi":"10.1177/1753465812463626","title":"The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"European Commission","keywords":"Medicine; COPD; Tiotropium bromide; Bronchodilation; Anticholinergic; Inhaler; Dry-powder inhaler; Pulmonary disease; Anesthesia; Pharmacology; Internal medicine; Bronchodilator; Asthma; Lung function; Lung","score_opus":0.05322175288162422,"score_gpt":0.382600312318969,"score_spread":0.3293785594373448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116275531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025003578,0.9899791,0.00015660544,0.00018619408,0.00055376114,0.008057065,0.0003786343,0.00003773762,0.00040090745],"genre_scores_gemma":[0.0067229136,0.9888159,0.0000601322,0.00021705941,0.00097096583,0.0024244306,0.00017733953,0.0001745728,0.00043667463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939611,0.00087204087,0.001541975,0.0010740828,0.0012150985,0.0013356947],"domain_scores_gemma":[0.99557704,0.0007530431,0.0006827679,0.0020233102,0.00014384024,0.0008199928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010607039,0.00092090626,0.001669622,0.00044585863,0.00025135852,0.000057235404,0.0014480579,0.00020316879,0.00008433014],"category_scores_gemma":[0.00007142475,0.0005698922,0.0011271766,0.0011217268,0.00084987545,0.000407403,0.00033696258,0.0009116288,0.000025100637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021794487,0.0009150766,0.0003971947,0.045373052,0.00035185335,0.00065688224,0.000034500714,0.00008663924,8.2400834e-7,0.0032141146,0.00002499622,0.9467654],"study_design_scores_gemma":[0.0022849815,0.00010118814,0.021209657,0.0073349713,0.004299643,0.000014516012,0.00027078294,0.0002047282,4.6794497e-7,0.004517882,0.9591592,0.00060197886],"about_ca_topic_score_codex":0.000006666993,"about_ca_topic_score_gemma":0.000009529244,"teacher_disagreement_score":0.9591342,"about_ca_system_score_codex":0.0011457686,"about_ca_system_score_gemma":0.0026178975,"threshold_uncertainty_score":0.9996753},"labels":[],"label_agreement":null},{"id":"W2116955665","doi":"10.1177/1753465810379009","title":"Immunomodulatory impact of a synbiotic in Th<sub>1</sub> and Th<sub>2</sub> models of infection","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège de Rosemont","funders":"","keywords":"Fructooligosaccharide; Bifidobacterium bifidum; Bifidobacterium longum; Enterotoxigenic Escherichia coli; Medicine; Nippostrongylus brasiliensis; Microbiology; Bifidobacterium; Lactobacillus; Probiotic; Tumor necrosis factor alpha; Cytokine; Synbiotics; Interleukin; Immunology; Escherichia coli; Enterotoxin; Biology; Food science; Bacteria; Fermentation; Immune system","score_opus":0.010901868174485923,"score_gpt":0.2940783271039692,"score_spread":0.2831764589294833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116955665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319507,0.015991064,0.00020640744,0.000008731747,0.00011800836,0.00038070467,0.000050372008,0.000010047229,0.000039622115],"genre_scores_gemma":[0.99682856,0.002858425,0.000021931199,0.00016405895,0.00005253472,0.000023227054,0.000018416249,0.000031867323,9.67003e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985178,0.00015101799,0.0004789407,0.00039685555,0.0001236486,0.0003317524],"domain_scores_gemma":[0.9990057,0.000029440209,0.0002375926,0.00049280835,0.00007992056,0.00015456206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003177733,0.00024907562,0.00033276208,0.00018797388,0.0000449115,0.000008792968,0.00014045223,0.0001821026,0.0000035558874],"category_scores_gemma":[0.00003706524,0.00023204251,0.00014051155,0.00019611628,0.00030257428,0.000042391035,0.00007576661,0.0002513301,0.0000013842352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004876189,0.00024709103,0.061808642,0.00018963228,0.0000311558,0.0000034274287,0.00006375622,0.001612096,0.9178431,0.00010718656,0.000002919391,0.017603349],"study_design_scores_gemma":[0.001613093,0.00053728354,0.52332264,0.00011868203,0.00004235157,0.0000033566757,0.00002458592,0.0004243018,0.4716733,0.0016754159,0.00023043442,0.0003345601],"about_ca_topic_score_codex":0.000026214411,"about_ca_topic_score_gemma":0.00024125075,"teacher_disagreement_score":0.461514,"about_ca_system_score_codex":0.000044671884,"about_ca_system_score_gemma":0.0003746221,"threshold_uncertainty_score":0.94624186},"labels":[],"label_agreement":null},{"id":"W2125851698","doi":"10.1177/1753465810396539","title":"The airway epithelium: more than just a structural barrier","year":2011,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Providence Health Care","funders":"","keywords":"Respiratory epithelium; Epithelium; Immunology; Immune system; Medicine; Secretion; Respiratory tract; Inflammation; Cell biology; Lung; Airway; Pathology; Biology; Respiratory system; Anatomy; Internal medicine","score_opus":0.1146398116142766,"score_gpt":0.4583542377047467,"score_spread":0.3437144260904701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125851698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000908708,0.9941199,0.000011532822,0.00009144604,0.00059949054,0.0038673985,0.0002098807,0.00012791381,0.0008815974],"genre_scores_gemma":[0.00015771927,0.9947102,0.000023609757,0.0018642109,0.0005962734,0.0012862966,0.00003397044,0.00026095496,0.0010667804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99333435,0.0011627099,0.0015706314,0.0012132608,0.0011823766,0.0015366605],"domain_scores_gemma":[0.994232,0.0009917777,0.0005933691,0.0024047983,0.00022866354,0.0015493855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012142474,0.0010715218,0.0021490974,0.00053867174,0.0005338819,0.00007231775,0.0012988498,0.00041770533,0.0004053779],"category_scores_gemma":[0.00057443604,0.0006431704,0.0008553086,0.00097595406,0.0012984105,0.0003593012,0.0003091531,0.002076297,0.00034048117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008370461,0.00006687233,0.0002179087,0.020814948,0.00011068526,0.0003827082,0.00007768449,8.9375595e-7,3.9661506e-7,0.00088806584,0.000026927897,0.97657585],"study_design_scores_gemma":[0.00094045396,0.00026086226,0.00041444652,0.006494893,0.00060142105,0.000017234237,0.00008827168,0.00000863452,0.0000017965432,0.0005848803,0.98998195,0.00060516],"about_ca_topic_score_codex":0.00000882965,"about_ca_topic_score_gemma":0.000040093902,"teacher_disagreement_score":0.989955,"about_ca_system_score_codex":0.0007129793,"about_ca_system_score_gemma":0.004339008,"threshold_uncertainty_score":0.99960196},"labels":[],"label_agreement":null},{"id":"W2144510249","doi":"10.1177/1753465812452193","title":"New treatment options for multidrug-resistant tuberculosis","year":2012,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Tuberculosis; Isoniazid; Rifabutin; Linezolid; Intensive care medicine; Drug resistance; Mycobacterium tuberculosis; Rifampicin; Drug; Multiple drug resistance; Extensively drug-resistant tuberculosis; Adverse effect; Pyrazinamide; Public health; Pharmacology; Internal medicine; Microbiology; Pathology; Clarithromycin","score_opus":0.14832583992827067,"score_gpt":0.45900512095469015,"score_spread":0.3106792810264195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144510249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011092056,0.99426895,0.00044318405,0.000240948,0.00026604804,0.00399721,0.00040107884,0.00009170597,0.00027978182],"genre_scores_gemma":[0.000044265962,0.99332374,0.0009088859,0.00080304785,0.00092155347,0.0028486073,0.00030487555,0.00014186083,0.0007031344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605817,0.0006104221,0.0010792357,0.0008215134,0.00031827227,0.0011124171],"domain_scores_gemma":[0.9960956,0.0010484111,0.00028298382,0.0010480316,0.00007490454,0.0014500746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005105763,0.0007703116,0.0025166245,0.00051066006,0.00013215112,0.000019444644,0.0002872706,0.00032401163,0.0002735874],"category_scores_gemma":[0.00024834252,0.00054094807,0.0012273061,0.0004212238,0.00017302818,0.00022097226,0.00005884596,0.00039072422,0.00016922095],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058668066,0.00052241946,0.00022860759,0.007887465,0.00040125736,0.000035360277,0.000021924092,0.000009035283,0.0000022250777,0.0008357279,0.00017630927,0.989293],"study_design_scores_gemma":[0.0017441794,0.00052043,0.00032224925,0.002949554,0.0033339856,0.000004843452,0.000016862938,0.00001973324,0.0000011647526,0.00035983455,0.99026114,0.00046603114],"about_ca_topic_score_codex":0.000025261175,"about_ca_topic_score_gemma":0.000059965656,"teacher_disagreement_score":0.9900848,"about_ca_system_score_codex":0.0010456203,"about_ca_system_score_gemma":0.0015171395,"threshold_uncertainty_score":0.9997042},"labels":[],"label_agreement":null},{"id":"W2145462863","doi":"10.1177/1753465809341965","title":"The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease","year":2009,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canada Research Chairs; Michael Smith Health Research BC; British Columbia Lung Association","keywords":"Pathogenesis; Medicine; Granzyme; Proteases; Granzyme A; Granzyme B; COPD; Immunology; Inflammation; Immune system; Biology; Perforin; CD8; Internal medicine; Enzyme","score_opus":0.01738806766172759,"score_gpt":0.3069382762385922,"score_spread":0.28955020857686464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145462863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012687977,0.99713194,0.000020217209,0.000009981063,0.00008601886,0.0011383364,0.00019426248,0.0000050801145,0.00014534472],"genre_scores_gemma":[0.03367496,0.9655073,0.0000073955484,0.00011922311,0.00017505247,0.00039865272,0.00006056169,0.000037938607,0.000018858402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735725,0.0007663733,0.00073065097,0.00048198213,0.00031071162,0.00035306098],"domain_scores_gemma":[0.9982105,0.00009450679,0.0004914318,0.0010287048,0.000056395853,0.00011847422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044815848,0.00039714115,0.0006505737,0.000106584375,0.00008756895,0.000012807743,0.000869568,0.00015758816,0.000005392558],"category_scores_gemma":[0.00006472269,0.00024014534,0.0004406525,0.00034813985,0.00028612532,0.00001651567,0.000097421456,0.00021775944,0.0000017925111],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002679656,0.0002705438,0.00008178316,0.0018054069,0.00003310629,0.000029955792,0.000015133964,0.000033288605,0.0014484521,0.00079821993,0.0000027903125,0.9952133],"study_design_scores_gemma":[0.00032321978,0.00025695653,0.0007948566,0.0020410002,0.00035599855,0.0000023141286,0.00009022118,0.000013187559,0.00095970783,0.009311865,0.9854306,0.0004200941],"about_ca_topic_score_codex":0.0000020342939,"about_ca_topic_score_gemma":0.000010645193,"teacher_disagreement_score":0.99479324,"about_ca_system_score_codex":0.000057804213,"about_ca_system_score_gemma":0.0007865382,"threshold_uncertainty_score":0.9792842},"labels":[],"label_agreement":null},{"id":"W2161944547","doi":"10.1177/1753465811398373","title":"The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease","year":2011,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; COPD; Intensive care medicine; Bronchodilator; Spirometry; Pharmacotherapy; Disease; Clinical trial; Quality of life (healthcare); Smoking cessation; Airway obstruction; Physical therapy; Asthma; Internal medicine; Airway; Anesthesia; Pathology","score_opus":0.05072413612063338,"score_gpt":0.385975998678867,"score_spread":0.33525186255823364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161944547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008636092,0.991701,0.000016217293,0.000048113907,0.00026928226,0.005518049,0.000459853,0.000065521555,0.0010583737],"genre_scores_gemma":[0.007636381,0.98862886,0.0000226762,0.0003023541,0.00033276572,0.002514591,0.00006150435,0.00026194472,0.00023889297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935629,0.001080178,0.0016334474,0.0014601466,0.0009366489,0.0013267075],"domain_scores_gemma":[0.99542254,0.00050764176,0.00055525446,0.0018636767,0.0002150831,0.0014358157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060311897,0.0011024505,0.0022337635,0.00093251385,0.0001895612,0.00003716505,0.0011899478,0.00022110317,0.00029552935],"category_scores_gemma":[0.0001163312,0.0008256504,0.0008443125,0.0015496504,0.0008914361,0.00041044477,0.00030611968,0.0011949713,0.00008453582],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004190007,0.0007625311,0.0020677955,0.012841118,0.00018805599,0.00046288306,0.00008386659,0.000115365656,0.000015993463,0.0011666819,0.0000052026257,0.9781005],"study_design_scores_gemma":[0.0013792207,0.000118788914,0.008094554,0.008370829,0.0007452788,0.000004937554,0.000114300834,0.00031189277,0.000020084251,0.005883914,0.974158,0.0007982247],"about_ca_topic_score_codex":0.000019587316,"about_ca_topic_score_gemma":0.00003112971,"teacher_disagreement_score":0.97730225,"about_ca_system_score_codex":0.0020161874,"about_ca_system_score_gemma":0.0045183115,"threshold_uncertainty_score":0.99941945},"labels":[],"label_agreement":null},{"id":"W2167795093","doi":"10.1177/1753465814559209","title":"Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials","year":2014,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"GlaxoSmithKline; Pfizer","keywords":"Medicine; COPD; Placebo; Internal medicine; Adverse effect; Crossover study; Gastroenterology","score_opus":0.03979873830986337,"score_gpt":0.3867703327110892,"score_spread":0.3469715944012258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167795093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661655,0.025076456,0.0001978155,0.00005646997,0.00026279228,0.007888383,0.000081998376,0.000034279223,0.00023631072],"genre_scores_gemma":[0.99767494,0.0008630039,0.000027013342,0.00015530693,0.00013343504,0.0009885905,0.00006152788,0.00007178789,0.000024416175],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9923604,0.0030091244,0.001977984,0.0008940978,0.0012062177,0.00055215077],"domain_scores_gemma":[0.9937124,0.0034413568,0.0010280791,0.0008833821,0.000341085,0.00059365743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002967843,0.0005003882,0.0024337193,0.00062839483,0.000052758412,0.000012285404,0.00036437457,0.00012247956,0.00005278508],"category_scores_gemma":[0.001263092,0.00038384128,0.0004884966,0.0006593903,0.0011711416,0.00042173406,0.00008816402,0.00054341584,0.000007663156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5664445,0.0034968022,0.34383374,0.0024893857,0.00010475485,0.00007050477,0.000037250724,0.0003449968,0.000055091274,0.0009967027,0.0000010377103,0.082125224],"study_design_scores_gemma":[0.34401003,0.00047655602,0.64927363,0.0020985766,0.0004943475,2.6111059e-7,0.000015117832,0.0010578266,0.00031257715,0.0019082348,0.00009736305,0.00025547427],"about_ca_topic_score_codex":0.000011434818,"about_ca_topic_score_gemma":0.0000080506,"teacher_disagreement_score":0.3054399,"about_ca_system_score_codex":0.00044193305,"about_ca_system_score_gemma":0.00071143964,"threshold_uncertainty_score":0.99986136},"labels":[],"label_agreement":null},{"id":"W2314437118","doi":"10.1177/1753465814565353","title":"Indwelling pleural catheters for pleural effusions associated with end-stage renal disease: a case series","year":2014,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Pleural and Pulmonary Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Mount Sinai Hospital; McGill University; Hôpital Charles-Le Moyne; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pleural effusion; Interquartile range; Pleurodesis; Surgery; Pleural disease; Thoracentesis; End stage renal disease; Empyema; Internal medicine; Respiratory disease; Lung; Hemodialysis","score_opus":0.0327486578812943,"score_gpt":0.30767867321266473,"score_spread":0.2749300153313704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314437118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507476,0.011128423,0.0006516836,0.00056273787,0.00013858294,0.0012493957,0.0008610613,0.0002092063,0.00012413054],"genre_scores_gemma":[0.994785,0.00012684784,0.00012508906,0.0033361472,0.00021307806,0.00041776837,0.0002703447,0.00007921205,0.00064649957],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975211,0.00026377264,0.00047542874,0.00062391773,0.00043320502,0.00068257045],"domain_scores_gemma":[0.9977336,0.00044505866,0.00020801972,0.00052896235,0.00012177781,0.00096260646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027469397,0.0004540691,0.0005137222,0.00019551397,0.00034509684,0.00004132541,0.00019257021,0.0000704287,0.00012553646],"category_scores_gemma":[0.0002881517,0.00034556934,0.00024327183,0.0003511244,0.00039823836,0.00055704877,0.00005024965,0.00025403593,0.0000074252116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07900913,0.005527048,0.6985418,0.0033636903,0.0008299639,0.04917584,0.00135449,0.016865332,0.00325593,0.005652662,0.00031858313,0.13610551],"study_design_scores_gemma":[0.033470135,0.0072151944,0.41611156,0.004336268,0.0043405495,0.0008705705,0.002069017,0.03177333,0.000948893,0.009414094,0.48448062,0.004969765],"about_ca_topic_score_codex":0.0000063714933,"about_ca_topic_score_gemma":0.00009180615,"teacher_disagreement_score":0.48416203,"about_ca_system_score_codex":0.00013774281,"about_ca_system_score_gemma":0.00033419192,"threshold_uncertainty_score":0.9998996},"labels":[],"label_agreement":null},{"id":"W2323157618","doi":"10.1177/1753465810386051","title":"Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population","year":2010,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cystic fibrosis; Epidemiology; Intensive care medicine; Population ageing; Disease; Population; Quality of life (healthcare); Pathology; Internal medicine; Environmental health; Nursing","score_opus":0.12473687055776012,"score_gpt":0.5099160943563219,"score_spread":0.3851792237985618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323157618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00622484,0.99138373,0.00030103335,0.000045932626,0.0003159563,0.0015890443,0.000036809648,0.00007943254,0.000023209712],"genre_scores_gemma":[0.0031973075,0.99335575,0.0019438269,0.0004060755,0.0005885145,0.00022065641,0.00014710054,0.000115595285,0.00002514499],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933009,0.002212868,0.001972846,0.0011844913,0.00036690466,0.0009619964],"domain_scores_gemma":[0.994618,0.0031442908,0.0005990247,0.000891694,0.00006413342,0.00068283564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003222984,0.000615148,0.0029466006,0.0011369531,0.00012546388,0.000039021954,0.00030069877,0.00047639484,0.000040752926],"category_scores_gemma":[0.0036736052,0.00051733124,0.0003245944,0.00076976523,0.000494336,0.0006017114,0.00016308995,0.0016508653,0.000013716412],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030501795,0.00017535654,0.035333794,0.008200627,0.000024478952,0.00021662266,0.000035540645,0.000021144026,0.0000025393788,0.0001174121,7.266998e-7,0.95556676],"study_design_scores_gemma":[0.0012596382,0.000530954,0.058622878,0.025095016,0.0006511053,0.00001496849,0.00008496517,0.0006229377,3.2883935e-7,0.0033288645,0.9090658,0.0007225837],"about_ca_topic_score_codex":0.000020295445,"about_ca_topic_score_gemma":0.00017868937,"teacher_disagreement_score":0.9548442,"about_ca_system_score_codex":0.0002642104,"about_ca_system_score_gemma":0.00033436454,"threshold_uncertainty_score":0.99972785},"labels":[],"label_agreement":null},{"id":"W2739450515","doi":"10.1177/1753465817717134","title":"Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Teva Pharmaceutical Industries; Merck","keywords":"Benralizumab; Medicine; Mepolizumab; Asthma; Eosinophil; Endotype; Immunology; Tolerability; Eosinophilia; Placebo; Internal medicine; Adverse effect; Pathology","score_opus":0.10045340493706947,"score_gpt":0.42733442022398904,"score_spread":0.3268810152869196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739450515","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12750505,0.8641887,4.1704592e-7,0.000057436002,0.00012779009,0.008052641,0.00003287228,0.000017219554,0.000017890927],"genre_scores_gemma":[0.14696881,0.8512924,0.000006427102,0.00017291172,0.0004855052,0.0010021712,0.000009709932,0.00005386458,0.000008235117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944637,0.0016574968,0.001796512,0.0010100862,0.0005849399,0.00048729405],"domain_scores_gemma":[0.99673915,0.00053525803,0.0011684535,0.0011018157,0.00009194694,0.00036339383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008808692,0.0007765712,0.003506822,0.00042842067,0.00010041094,0.000049860162,0.00037184719,0.00034291358,0.0000056074114],"category_scores_gemma":[0.00033412638,0.00041288373,0.0003747134,0.00039886642,0.0008034352,0.0002822452,0.000044746772,0.00057913625,0.0000014765457],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14331128,0.0039418475,0.028597102,0.010984294,0.0001117244,0.0011881996,0.00015609011,6.9498986e-7,1.2413618e-7,0.000031994612,6.1331144e-7,0.811676],"study_design_scores_gemma":[0.31938675,0.018260162,0.07984242,0.13126847,0.0033466683,0.0000312337,0.0003346071,0.000015370391,5.8299986e-7,0.00012850428,0.44645062,0.0009346238],"about_ca_topic_score_codex":0.000006707047,"about_ca_topic_score_gemma":0.00010108146,"teacher_disagreement_score":0.8107414,"about_ca_system_score_codex":0.0001385017,"about_ca_system_score_gemma":0.0013236746,"threshold_uncertainty_score":0.9998323},"labels":[],"label_agreement":null},{"id":"W2786507366","doi":"10.1177/1753465817751346","title":"A review of the <i>in vitro</i> and <i>in vivo</i> valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trudell Medical International (Canada)","funders":"","keywords":"Medicine; Inhalation; Anesthesia","score_opus":0.032782377650710806,"score_gpt":0.327184581321307,"score_spread":0.2944022036705962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786507366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013855087,0.9936643,0.000007440834,0.00030755362,0.00018160192,0.003654351,0.000119626355,0.000027440296,0.0006521473],"genre_scores_gemma":[0.0022272526,0.98192453,0.000027142849,0.01495366,0.00017081464,0.0004553723,0.00001330599,0.000112530244,0.000115399824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954247,0.0012722095,0.0012712966,0.00081591815,0.00067771284,0.0005381726],"domain_scores_gemma":[0.99709725,0.00055530434,0.00073600595,0.0012539299,0.00015086285,0.00020665025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011010966,0.00079669023,0.0021293815,0.00037976718,0.00011188596,0.00003577593,0.00034416604,0.0002411241,0.00007152661],"category_scores_gemma":[0.00017922606,0.00039366476,0.00046783677,0.0015946183,0.000570501,0.00020329897,0.00011383503,0.0010807035,0.000012007737],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049322587,0.0015885342,0.0005847233,0.4494713,0.00061594346,0.0017381035,0.0015854752,0.00020322588,0.00016455569,0.000554116,0.0011943656,0.5373674],"study_design_scores_gemma":[0.0018898239,0.00012541984,0.000048975453,0.29670256,0.0006945646,0.000027830065,0.000048110265,0.00008019646,0.00006127061,0.0000598075,0.6997674,0.0004940538],"about_ca_topic_score_codex":0.0000018427878,"about_ca_topic_score_gemma":0.000015800319,"teacher_disagreement_score":0.69857305,"about_ca_system_score_codex":0.00025977692,"about_ca_system_score_gemma":0.0008467641,"threshold_uncertainty_score":0.9998515},"labels":[],"label_agreement":null},{"id":"W2794058912","doi":"10.1177/1753465818755091","title":"Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Université Laval; Boehringer Ingelheim (Canada); Institut universitaire de cardiologie et de pneumologie de Québec","funders":"AstraZeneca","keywords":"Medicine; Placebo; COPD; Clinical endpoint; Anesthesia; Physical therapy; Internal medicine; Randomized controlled trial","score_opus":0.01422962630954417,"score_gpt":0.309660806687224,"score_spread":0.29543118037767985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794058912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94087464,0.056571197,0.000022352307,0.000050214054,0.00018287348,0.0017535079,0.00013242816,0.000049894694,0.00036286702],"genre_scores_gemma":[0.99714017,0.0021522075,0.000028875143,0.000084587846,0.00017752594,0.000274485,0.000013580373,0.00008222874,0.00004634877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958994,0.00066229043,0.0009109272,0.0010188336,0.0006844591,0.00082410214],"domain_scores_gemma":[0.99743664,0.00053570553,0.0003893514,0.0009096326,0.00014834122,0.0005803422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055505644,0.00055130105,0.0009820755,0.0005192962,0.00013109106,0.000017377182,0.00034255738,0.00011745745,0.00013049187],"category_scores_gemma":[0.00022931062,0.000499681,0.00018458028,0.0006576035,0.0017862967,0.00052083965,0.0001693353,0.00053823256,0.000012142088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048898906,0.00062000356,0.64946955,0.0066793095,0.00008928116,0.0011536292,0.0003514228,0.0010605375,0.03563626,0.000202754,0.0000010101376,0.25583732],"study_design_scores_gemma":[0.0058081164,0.000477934,0.9725146,0.0046650334,0.00018380779,0.000003763532,0.00012579521,0.0012259735,0.013820523,0.00054796005,0.00019320723,0.00043327437],"about_ca_topic_score_codex":0.000011265082,"about_ca_topic_score_gemma":0.000012335707,"teacher_disagreement_score":0.32304505,"about_ca_system_score_codex":0.00080354523,"about_ca_system_score_gemma":0.0005544125,"threshold_uncertainty_score":0.9997455},"labels":[],"label_agreement":null},{"id":"W2916686429","doi":"10.1177/1753466618824010","title":"Safety of tiotropium in patients with asthma","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Boehringer Ingelheim","keywords":"Medicine; Asthma; Tiotropium bromide; Intensive care medicine; Bronchodilator Agents; Internal medicine; Bronchodilator; Lung function; Lung","score_opus":0.025922716678020357,"score_gpt":0.33720014522506214,"score_spread":0.31127742854704177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916686429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013247047,0.99511266,0.00002396193,0.0000049675277,0.00016396078,0.002585877,0.00021403852,0.000035475212,0.00053437223],"genre_scores_gemma":[0.0025969665,0.9962873,0.000027276514,0.00042483906,0.00010740859,0.00017066422,0.00013958309,0.00013948884,0.000106513646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996492,0.00038679157,0.0012151161,0.0007382455,0.00066850457,0.0004993189],"domain_scores_gemma":[0.99771553,0.00016731971,0.00062053493,0.0010144,0.00012645131,0.00035578877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018726118,0.0006687543,0.002465521,0.0006530401,0.00003279042,0.0000091063675,0.0003227643,0.00023005743,0.00015847286],"category_scores_gemma":[0.00005687973,0.00046041916,0.0004374945,0.00079313066,0.00030629695,0.00024154958,0.00007479422,0.0005226525,0.00005836061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019464308,0.00097182073,0.061919086,0.025192454,0.000075751545,0.00008680592,0.00001409445,0.0000513091,6.6684905e-8,0.00009248791,0.0000059760305,0.9096437],"study_design_scores_gemma":[0.003590412,0.00061596226,0.059456468,0.01947931,0.0005905682,5.6638913e-7,0.000015804926,0.0000025049937,2.2405634e-7,0.000021867125,0.915768,0.00045827427],"about_ca_topic_score_codex":0.0000011009644,"about_ca_topic_score_gemma":0.000005165475,"teacher_disagreement_score":0.91576207,"about_ca_system_score_codex":0.00031358548,"about_ca_system_score_gemma":0.0015152929,"threshold_uncertainty_score":0.99978477},"labels":[],"label_agreement":null},{"id":"W2945060451","doi":"10.1177/1753466619850725","title":"Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; COPD; Lama; Formoterol; Formoterol Fumarate; Bronchodilator; Quality of life (healthcare); Tiotropium bromide; Obstructive lung disease; Clinical trial; Internal medicine; Minimal clinically important difference; Muscarinic antagonist; Intensive care medicine; Physical therapy; Corticosteroid; Asthma; Randomized controlled trial; Lung; Lung function; Budesonide; Antagonist","score_opus":0.10790276519644681,"score_gpt":0.405512090307414,"score_spread":0.29760932511096716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945060451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014295305,0.97758883,0.000021035708,0.0002915572,0.00010089812,0.007174851,0.00009515041,0.000022461125,0.00040989107],"genre_scores_gemma":[0.074291304,0.9224558,0.000020805437,0.0015103081,0.000052459527,0.0014213132,0.00008409197,0.00009677977,0.000067137276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942979,0.001867861,0.0010463266,0.00093457673,0.0012039576,0.000649363],"domain_scores_gemma":[0.9962648,0.00087185926,0.00052900123,0.0020149047,0.00010352653,0.00021589376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018694656,0.0006514123,0.0013205066,0.0005887945,0.000076246935,0.000045089815,0.0011210142,0.00013712059,0.00012446468],"category_scores_gemma":[0.000066007786,0.0003665003,0.00025386378,0.0012940703,0.00043904947,0.0006032623,0.00016229395,0.0009833314,0.000058026842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035213234,0.0015435511,0.0021085325,0.038272828,0.00014765297,0.0008642863,0.000136917,0.0001897736,0.0000013938181,0.0033467116,0.000014203818,0.9498528],"study_design_scores_gemma":[0.018960314,0.0034347987,0.13250262,0.21262176,0.0041625807,0.000028839522,0.0027406092,0.002210143,0.000015207164,0.0042032194,0.6166162,0.0025037387],"about_ca_topic_score_codex":0.000010518333,"about_ca_topic_score_gemma":0.00004439225,"teacher_disagreement_score":0.9473491,"about_ca_system_score_codex":0.0008133571,"about_ca_system_score_gemma":0.00077793625,"threshold_uncertainty_score":0.9998787},"labels":[],"label_agreement":null},{"id":"W2986277578","doi":"10.1177/1753466619888127","title":"Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Prednisone; Sarcoidosis; Concomitant; Medical record; Internal medicine; Corticosteroid; Retrospective cohort study; Surgery","score_opus":0.009863409826258163,"score_gpt":0.30863826396228006,"score_spread":0.2987748541360219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986277578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437416,0.0040031965,0.000058264057,0.000063477775,0.00011203156,0.00093327166,0.000012702143,0.000034523884,0.00040839257],"genre_scores_gemma":[0.99901104,0.0003409477,0.000043258267,0.00038615335,0.000028454184,0.0000981192,0.000017387247,0.000030669784,0.00004398327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637806,0.00027984072,0.0007414567,0.0005585968,0.0016537202,0.00038834268],"domain_scores_gemma":[0.99843127,0.00014850902,0.0002662402,0.00065728143,0.00021054149,0.00028617305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003287004,0.00023952452,0.0008288119,0.0009547674,0.000036937803,0.000013516944,0.00022863998,0.0001224764,0.00024176315],"category_scores_gemma":[0.0001626292,0.00018839561,0.00016774543,0.002280944,0.00021620291,0.0003209775,0.000054301927,0.00039802102,0.000008035023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029194446,0.0012262956,0.9767186,0.00023385501,0.0002928857,0.000027474462,0.00011419783,0.0007980906,0.00025908646,0.00009935628,0.0000010697779,0.017309634],"study_design_scores_gemma":[0.0045406367,0.0013922736,0.99009705,0.00059829117,0.0004093726,5.2156656e-7,0.00016234601,0.0022276803,0.00020944176,0.00006617722,0.00009525847,0.00020096281],"about_ca_topic_score_codex":0.000029385228,"about_ca_topic_score_gemma":0.000111714704,"teacher_disagreement_score":0.017108671,"about_ca_system_score_codex":0.0004307484,"about_ca_system_score_gemma":0.0003706935,"threshold_uncertainty_score":0.768255},"labels":[],"label_agreement":null},{"id":"W2988803771","doi":"10.1177/1753466619888131","title":"Duration of sweep gas off trial for weaning from venovenous extracorporeal membrane oxygenation","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Samsung Medical Center, Sungkyunkwan University","keywords":"Medicine; Extracorporeal membrane oxygenation; Anesthesia; Weaning; Arterial blood; Oxygenation; Internal medicine","score_opus":0.020771647762006403,"score_gpt":0.271040637602106,"score_spread":0.2502689898400996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988803771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795855,0.012857795,0.004902033,0.000010246988,0.0007369354,0.0012743392,0.00009059819,0.00012717234,0.000415328],"genre_scores_gemma":[0.99920714,0.000073090814,0.0001758639,0.00012537172,0.00017543901,0.00013215077,0.000059390375,0.00004330122,0.000008255448],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985091,0.00006836728,0.0006178805,0.00028955753,0.00028018176,0.00023491833],"domain_scores_gemma":[0.9990728,0.00022715509,0.00017956118,0.0003552119,0.000051367966,0.000113939524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029553866,0.00019092383,0.0003240173,0.000115525865,0.000028374192,0.000014531197,0.00019560233,0.000083826104,0.00018807247],"category_scores_gemma":[0.000048347316,0.00019820406,0.00010480678,0.00016108877,0.00002984431,0.00044163867,0.000012629886,0.000115294795,0.000019594045],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033633232,0.00096566085,0.013877814,0.0023362224,0.00034029968,0.00004232201,0.0009517625,0.20420292,0.15899082,0.014664452,0.000021122529,0.56997335],"study_design_scores_gemma":[0.16124289,0.0027210903,0.05600265,0.00109759,0.00085838314,0.0000018971272,0.0008949309,0.43938696,0.061205182,0.096215546,0.1767325,0.003640397],"about_ca_topic_score_codex":0.0000026628718,"about_ca_topic_score_gemma":0.000016849212,"teacher_disagreement_score":0.566333,"about_ca_system_score_codex":0.00008505189,"about_ca_system_score_gemma":0.000065500484,"threshold_uncertainty_score":0.80825263},"labels":[],"label_agreement":null},{"id":"W3031067427","doi":"10.1177/1753466620926858","title":"Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO<sup>®</sup> clinical trial","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre; Université Laval; Boehringer Ingelheim (Canada); Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Boehringer Ingelheim","keywords":"Medicine; COPD; Placebo; Bronchodilator; Physical therapy; Intraclass correlation; Confidence interval; Internal medicine; Asthma","score_opus":0.18241283262734345,"score_gpt":0.38076633105621716,"score_spread":0.1983534984288737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031067427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86292785,0.13106097,0.000046196412,0.002309569,0.00010765678,0.0031914483,0.000022363418,0.00002979943,0.0003041542],"genre_scores_gemma":[0.99607086,0.0010246625,0.00001527933,0.0022835792,0.0002656554,0.00029989076,0.0000017772201,0.000028741002,0.000009526447],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9954879,0.0016126258,0.0010775557,0.00057072897,0.00081354944,0.00043762857],"domain_scores_gemma":[0.9973069,0.0013492436,0.00029664856,0.0005190712,0.00020642177,0.00032170978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002383762,0.00030679523,0.0008470472,0.00007659663,0.00014591526,0.00003632405,0.00035424263,0.0000662404,0.000043715023],"category_scores_gemma":[0.0016969289,0.00017551822,0.00017518696,0.00055073557,0.0022349034,0.00023638879,0.00014691436,0.00072284794,0.000007484431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4845932,0.0027223097,0.38080847,0.001989521,0.00046864134,0.0003266881,0.01045638,0.0042374604,0.002240848,0.0015156132,0.00006597217,0.11057491],"study_design_scores_gemma":[0.2841725,0.001682093,0.62271863,0.005499959,0.0009896174,0.0000057944817,0.02234587,0.031587787,0.0014997376,0.0026964478,0.025360435,0.0014411105],"about_ca_topic_score_codex":0.000006556809,"about_ca_topic_score_gemma":0.000014929622,"teacher_disagreement_score":0.24191019,"about_ca_system_score_codex":0.00020894023,"about_ca_system_score_gemma":0.00080924045,"threshold_uncertainty_score":0.82345945},"labels":[],"label_agreement":null},{"id":"W3032084356","doi":"10.1177/1753466620926949","title":"Early and sustained symptom improvement with umeclidinium/vilanterol <i>versus</i> monotherapy in COPD: a <i>post hoc</i> analysis of the EMAX randomised controlled trial","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"GlaxoSmithKline","keywords":"Medicine; Post-hoc analysis; COPD; Randomized controlled trial; Post hoc; Internal medicine; Physical therapy","score_opus":0.016085650263851812,"score_gpt":0.2997480114759901,"score_spread":0.2836623612121383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032084356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97306305,0.017795974,0.00007452971,0.0009709416,0.000083941886,0.007653518,0.00012173134,0.00003501162,0.00020131934],"genre_scores_gemma":[0.9945561,0.00056142133,0.000012716248,0.0037993432,0.00009266075,0.000881434,0.000012373967,0.000050544444,0.000033386463],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965431,0.0005349776,0.0008685005,0.00070954295,0.000819294,0.00052458036],"domain_scores_gemma":[0.99772584,0.00057549885,0.00036792888,0.00065732026,0.00019812628,0.00047529253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046113654,0.00040984157,0.0013527869,0.00037358952,0.0000804798,0.000032911874,0.0003331502,0.00008211431,0.00011768096],"category_scores_gemma":[0.00016948416,0.0002677524,0.0004157751,0.001487546,0.0005076747,0.00025888855,0.00009561819,0.00035188047,0.0000013735591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95192,0.00063696806,0.032903012,0.00031398732,0.0012546536,0.000115094634,0.00057545,0.00040015497,0.0020192321,0.00012828123,0.0000032883868,0.009729915],"study_design_scores_gemma":[0.9318875,0.0029545147,0.056783583,0.00013397342,0.002205111,3.7640012e-7,0.00095609593,0.0036833435,0.0001887381,0.000070427894,0.00079730694,0.00033901117],"about_ca_topic_score_codex":0.000017301416,"about_ca_topic_score_gemma":0.00007942354,"teacher_disagreement_score":0.023880571,"about_ca_system_score_codex":0.00025796337,"about_ca_system_score_gemma":0.0007446011,"threshold_uncertainty_score":0.99997747},"labels":[],"label_agreement":null},{"id":"W3042800647","doi":"10.1177/1753466620939507","title":"Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium <i>versus</i> tiotropium: the RED trial","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Kingston Health Sciences Centre; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Novartis","keywords":"Indacaterol; Medicine; COPD; Bronchodilator; Anesthesia; Confidence interval; Internal medicine; Cardiology; Inhalation; Bronchodilation; Asthma","score_opus":0.019741420308812645,"score_gpt":0.28173288360238147,"score_spread":0.2619914632935688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042800647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883694,0.004530028,0.000021606462,0.0026163412,0.00013813263,0.0031477937,0.00011265966,0.00006770884,0.00052881485],"genre_scores_gemma":[0.9973288,0.000118839074,0.000023082408,0.0018736598,0.00027490885,0.00021822247,0.000036892096,0.00007352732,0.000052021947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965679,0.00032758276,0.0005514738,0.0007082363,0.001179668,0.0006651298],"domain_scores_gemma":[0.9980512,0.00043831227,0.00021773047,0.00069123995,0.00017347797,0.00042802628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026199262,0.00040184843,0.00044863974,0.00012726006,0.00025201862,0.000056274454,0.00044592327,0.00006992354,0.00024309775],"category_scores_gemma":[0.00022160508,0.00021178037,0.00009302342,0.0007972175,0.0009354645,0.00038665647,0.00013663745,0.0007188074,0.000023661834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27355242,0.0009721645,0.71944636,0.00039701822,0.0000999875,0.00027076335,0.00031751086,0.00085537176,0.0003659566,0.00010297913,0.00004441253,0.0035750824],"study_design_scores_gemma":[0.101513155,0.0016373311,0.88539916,0.00036620887,0.00018210712,0.0000020158768,0.00058565324,0.0003772042,0.00017119395,0.00008578217,0.00925962,0.000420544],"about_ca_topic_score_codex":0.000006707289,"about_ca_topic_score_gemma":0.000035956156,"teacher_disagreement_score":0.17203926,"about_ca_system_score_codex":0.0006118688,"about_ca_system_score_gemma":0.0008884601,"threshold_uncertainty_score":0.8636153},"labels":[],"label_agreement":null},{"id":"W3083947977","doi":"10.1177/1753466620951044","title":"Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Pulmonary disease; Qualitative research; Intensive care medicine; COPD; Intervention (counseling); Disease; Chronic disease; Physical therapy; Nursing; Internal medicine","score_opus":0.03790354924791903,"score_gpt":0.4112889076843821,"score_spread":0.37338535843646303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083947977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8191754,0.16925019,0.0005644263,0.0010700152,0.00015562118,0.008568943,0.0004610708,0.0001438849,0.00061040925],"genre_scores_gemma":[0.99606055,0.00033797283,0.000060348775,0.0013624814,0.00020171389,0.0017343622,0.000047115587,0.00007925886,0.00011618972],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99533445,0.0011634167,0.0008465678,0.0010261725,0.0009838429,0.0006455717],"domain_scores_gemma":[0.99706775,0.00017932603,0.00029958182,0.00074467016,0.00016612078,0.0015425776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005277186,0.0004321573,0.0007919885,0.00038533562,0.00011130624,0.000019837371,0.00041208987,0.000047107827,0.00023608329],"category_scores_gemma":[0.00018692561,0.0004130576,0.00031171858,0.0011416264,0.0003596148,0.00041685844,0.00026427725,0.00044077547,0.000034750752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016945679,0.0061255884,0.048952468,0.007637501,0.0003239662,0.0008473638,0.026331136,0.0012621667,0.00043635242,0.0013638765,0.00004669814,0.88972723],"study_design_scores_gemma":[0.004286272,0.0034085766,0.9282247,0.00072138105,0.00022852531,0.0000015482614,0.04688347,0.00033647276,0.000059272177,0.0029226486,0.0123893805,0.00053775025],"about_ca_topic_score_codex":0.00003983542,"about_ca_topic_score_gemma":0.00005089203,"teacher_disagreement_score":0.8891895,"about_ca_system_score_codex":0.0010042258,"about_ca_system_score_gemma":0.0007466578,"threshold_uncertainty_score":0.99983215},"labels":[],"label_agreement":null},{"id":"W3093952199","doi":"10.1177/1753466620965145","title":"Effect of once-daily fluticasone furoate/vilanterol <i>versus</i> vilanterol alone on bone mineral density in patients with COPD: a randomized, controlled trial","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"GlaxoSmithKline","keywords":"Medicine; Bone mineral; COPD; Randomized controlled trial; Clinical endpoint; Bone density; Internal medicine; Fluticasone propionate; Confidence interval; Osteoporosis; Corticosteroid","score_opus":0.013222180757705667,"score_gpt":0.2978002699930624,"score_spread":0.28457808923535677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093952199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98029256,0.0076723546,0.00004896914,0.00028862996,0.0002143404,0.011031508,0.00010052491,0.00006440013,0.00028672058],"genre_scores_gemma":[0.99642634,0.00019830381,0.0000184901,0.002103532,0.00019660531,0.0009098683,0.00005072229,0.00007719299,0.00001895132],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99392116,0.001982597,0.0011634888,0.0008903506,0.0013295562,0.00071284926],"domain_scores_gemma":[0.99648297,0.0015214854,0.00042885356,0.0006684246,0.0001808253,0.0007174646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010176889,0.00062434544,0.0029899077,0.00034088007,0.000060322818,0.000021386442,0.00028918567,0.000121220364,0.00012104353],"category_scores_gemma":[0.00090239744,0.00043359227,0.0004953963,0.0005703028,0.0007332645,0.00027735953,0.00009872108,0.0005887661,0.000025924719],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9252707,0.0016418687,0.06386689,0.0007556337,0.0003115863,0.00059756194,0.00010146199,0.00018525355,0.00023095672,0.00002400356,0.000023146618,0.006990975],"study_design_scores_gemma":[0.9670067,0.006800174,0.022439882,0.00045493204,0.0007285513,0.0000012547142,0.000030006668,0.0017073691,0.0002161485,0.000024127616,0.00023464047,0.00035621386],"about_ca_topic_score_codex":0.000007679199,"about_ca_topic_score_gemma":0.000012670474,"teacher_disagreement_score":0.041736037,"about_ca_system_score_codex":0.0003075383,"about_ca_system_score_gemma":0.00037197242,"threshold_uncertainty_score":0.9998116},"labels":[],"label_agreement":null},{"id":"W3095540331","doi":"10.1177/1753466620968497","title":"Effect of post-extubation high-flow nasal cannula on reintubation in elderly patients: a retrospective propensity score-matched cohort study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Samsung Medical Center, Sungkyunkwan University","keywords":"Nasal cannula; Medicine; Propensity score matching; Anesthesia; Intensive care unit; Retrospective cohort study; Oxygen therapy; Respiratory failure; Cannula; Surgery; Internal medicine","score_opus":0.018937470891784155,"score_gpt":0.29307823109547365,"score_spread":0.2741407602036895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095540331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941104,0.00039446264,0.00012086596,0.00009665242,0.0001695862,0.004852961,0.000035493395,0.0000632708,0.00015632152],"genre_scores_gemma":[0.9982497,0.000026203006,0.000016148493,0.0011803068,0.000082077866,0.000333366,0.000057378882,0.00004391514,0.000010896784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970625,0.00058766175,0.00064963155,0.0006615397,0.000735362,0.00030330094],"domain_scores_gemma":[0.9986489,0.0000952091,0.0002885099,0.00044715076,0.00023694233,0.00028328618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006614809,0.00033169377,0.0007563705,0.00023444425,0.00005319847,0.000013296556,0.00015339996,0.00009100309,0.000085993895],"category_scores_gemma":[0.00045339885,0.00027483708,0.00010178452,0.0005650795,0.00008913635,0.00037180202,0.00004169655,0.00032995615,0.000015993974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010862402,0.0009975849,0.92673343,0.00022736218,0.00004337972,0.00006450861,0.0004974497,0.00031408007,0.0009124292,0.00006388311,0.0000039702823,0.05927952],"study_design_scores_gemma":[0.007412342,0.023879513,0.9645533,0.00018076465,0.00015635553,1.1823736e-7,0.00011117211,0.00024163279,0.0028454284,0.00016083436,0.00021164014,0.00024687967],"about_ca_topic_score_codex":0.000027732589,"about_ca_topic_score_gemma":0.00008259695,"teacher_disagreement_score":0.05903264,"about_ca_system_score_codex":0.00031178776,"about_ca_system_score_gemma":0.00023237558,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W3103372623","doi":"10.1177/1753466620968500","title":"Impact of baseline COPD symptom severity on the benefit from dual <i>versus</i> mono-bronchodilators: an analysis of the EMAX randomised controlled trial","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; COPD; Salmeterol; Post-hoc analysis; Exacerbation; Bronchodilator; Population; Internal medicine; Physical therapy; Asthma","score_opus":0.03581698791034,"score_gpt":0.34694200851240753,"score_spread":0.31112502060206754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103372623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98468024,0.008678672,0.00006265899,0.0004829741,0.00015991498,0.004477229,0.0012294314,0.00003618769,0.00019271807],"genre_scores_gemma":[0.9976247,0.00017470017,0.00001003057,0.0014817475,0.00030154485,0.00028789483,0.00006225024,0.000044853714,0.000012265653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99525326,0.0013749572,0.0010553915,0.0006831073,0.0011903209,0.00044293943],"domain_scores_gemma":[0.9948996,0.002284896,0.00057297107,0.0013584372,0.00026638844,0.00061773683],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008224026,0.00043945885,0.0015191954,0.00021777255,0.00012172085,0.000020519783,0.0005749449,0.00010667645,0.0012464589],"category_scores_gemma":[0.0010960937,0.00024899116,0.001393807,0.001377916,0.0006390373,0.0002534647,0.00011972133,0.0004559537,0.0000051964353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9209877,0.0014628822,0.054695502,0.00009207103,0.002801704,0.000029587864,0.00032112355,0.010259121,0.0009025464,0.00020147588,0.000020358215,0.008225928],"study_design_scores_gemma":[0.59378994,0.0013583286,0.3544932,0.00011306551,0.0053861043,1.31681e-7,0.00044687575,0.042960912,0.00031253602,0.00038889004,0.00039962676,0.0003503539],"about_ca_topic_score_codex":0.000067504865,"about_ca_topic_score_gemma":0.000038843547,"teacher_disagreement_score":0.32719773,"about_ca_system_score_codex":0.00037766507,"about_ca_system_score_gemma":0.0009914911,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W3112593559","doi":"10.1177/1753466620976021","title":"Therapeutic interventions for COVID-19: a living overview of reviews","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Systematic review; Psychological intervention; Intensive care medicine; MEDLINE; Coronavirus disease 2019 (COVID-19); Cochrane Library; Alternative medicine; Disease; Pathology; Infectious disease (medical specialty); Psychiatry","score_opus":0.45211641919045664,"score_gpt":0.6031299803789213,"score_spread":0.15101356118846465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112593559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.811575e-7,0.98336446,0.007828799,0.00058355473,0.0001745017,0.0076095634,0.00030462918,0.0000836541,0.000050682356],"genre_scores_gemma":[0.000046967874,0.9857597,0.00016011037,0.009658146,0.00026714342,0.0037912484,0.000036480138,0.00012351216,0.00015669857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99332815,0.0014877216,0.0028117755,0.0010970641,0.000629307,0.0006459925],"domain_scores_gemma":[0.9787095,0.016710503,0.0014926897,0.001496783,0.00020270077,0.0013878146],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002512777,0.00076986453,0.0050975196,0.00051100465,0.00013397762,0.000022782018,0.0007440214,0.00021724692,0.00037672845],"category_scores_gemma":[0.042171255,0.0005773732,0.0035737413,0.0011637225,0.00057223457,0.00018047562,0.000366105,0.0007954806,0.00005207085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017123407,0.0003821612,0.00010186988,0.33365837,0.00025701907,0.00003249315,0.000052496474,0.0000068796103,2.2989695e-7,0.00054906704,0.000058720605,0.6647295],"study_design_scores_gemma":[0.0008227436,0.0005389106,0.0000616271,0.09434077,0.0030717256,5.050443e-7,0.000017341155,0.0000324668,8.086955e-8,0.0014187723,0.8992977,0.00039734144],"about_ca_topic_score_codex":0.0000031978802,"about_ca_topic_score_gemma":0.000011080502,"teacher_disagreement_score":0.899239,"about_ca_system_score_codex":0.00074423704,"about_ca_system_score_gemma":0.0036800911,"threshold_uncertainty_score":0.99966776},"labels":[],"label_agreement":null},{"id":"W3143595100","doi":"10.1177/17534666211001013","title":"The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"GlaxoSmithKline","keywords":"Medicine; COPD; Fluticasone propionate; Internal medicine; Pulmonary disease; Obstructive lung disease; Physical therapy; Corticosteroid","score_opus":0.037776706612528826,"score_gpt":0.3839593870275702,"score_spread":0.3461826804150414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143595100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88871104,0.10720729,0.000007200486,0.0008240375,0.00007043558,0.0027427364,0.0001282922,0.000026513035,0.00028247604],"genre_scores_gemma":[0.99764246,0.0010301312,0.0000027856092,0.00051240966,0.00013157037,0.0005344018,0.000052250838,0.000060240305,0.0000337764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941991,0.0021262537,0.00086703023,0.00084873097,0.001108875,0.00085000653],"domain_scores_gemma":[0.9967869,0.00088812655,0.00022622429,0.0014899728,0.0001734896,0.000435305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00099312,0.00043971327,0.00056884193,0.00036426669,0.00019591846,0.00004123063,0.00053729926,0.0000784149,0.00006921473],"category_scores_gemma":[0.0003817198,0.00029026018,0.00026921852,0.0014076483,0.00053661445,0.00030383767,0.00015139113,0.0008746177,0.0000068369623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010447772,0.0025419309,0.90583986,0.0006490378,0.00007612731,0.002979463,0.0009906756,0.0035271945,0.00018656073,0.00042982274,0.000010527311,0.07232104],"study_design_scores_gemma":[0.003093662,0.00044436686,0.9821717,0.0004543638,0.00008572354,0.000008023322,0.006264975,0.004786535,0.000024980765,0.0016600692,0.00076385145,0.000241722],"about_ca_topic_score_codex":0.000079129335,"about_ca_topic_score_gemma":0.000312911,"teacher_disagreement_score":0.108931415,"about_ca_system_score_codex":0.002470489,"about_ca_system_score_gemma":0.0024099785,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W3196823965","doi":"10.1177/17534666211009407","title":"The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; ARDS; Prone position; Intubation; Randomized controlled trial; Confidence interval; Supine position; Anesthesia; Internal medicine; Lung","score_opus":0.03906706691444746,"score_gpt":0.34934723654635474,"score_spread":0.3102801696319073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196823965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015164048,0.9821059,0.00016334349,0.00002157769,0.000039717237,0.0023561702,0.000088391884,0.000018860654,0.000041985713],"genre_scores_gemma":[0.021423599,0.9763629,0.00022030494,0.0006286743,0.00006245118,0.0010140552,0.0001313097,0.00010298985,0.00005372802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964459,0.0005387012,0.001182412,0.0008467619,0.00058870716,0.0003975429],"domain_scores_gemma":[0.9975548,0.00036610468,0.0007736328,0.000831165,0.00021029261,0.00026404537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064679264,0.00060854916,0.0030717852,0.0005834214,0.00013576177,0.000053058753,0.00020256583,0.00019593317,0.000029696594],"category_scores_gemma":[0.00007497478,0.00037693937,0.0005430827,0.0013102171,0.00031649563,0.00031205348,0.00008466881,0.0005102824,0.0000013202433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011097493,0.00059830665,0.006656982,0.007070949,0.026994992,0.0003566368,0.00021212045,0.00008407659,0.000014975114,0.00024273428,0.000007508283,0.956651],"study_design_scores_gemma":[0.0068532918,0.001633541,0.00972975,0.0061574867,0.3125727,0.0000083932155,0.00020372053,0.000047985326,0.000023969009,0.0001619733,0.661375,0.0012322164],"about_ca_topic_score_codex":0.0000019735571,"about_ca_topic_score_gemma":0.000043635424,"teacher_disagreement_score":0.95541877,"about_ca_system_score_codex":0.00014253006,"about_ca_system_score_gemma":0.0007107187,"threshold_uncertainty_score":0.9998683},"labels":[],"label_agreement":null},{"id":"W4290652231","doi":"10.1177/17534666221117002","title":"Immunomodulatory treatment of interstitial lung disease","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Interstitial lung disease; Idiopathic pulmonary fibrosis; Azathioprine; Hypersensitivity pneumonitis; Usual interstitial pneumonia; Idiopathic interstitial pneumonia; Cyclophosphamide; Rituximab; Cryptogenic Organizing Pneumonia; Pirfenidone; Pneumocystis pneumonia; Immunology; Pneumonia; Disease; Lung; Internal medicine; Pneumocystis jirovecii; Chemotherapy; Lymphoma","score_opus":0.05989031968838481,"score_gpt":0.38635835832073984,"score_spread":0.326468038632355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290652231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007572619,0.9954855,0.000052693165,0.000013072502,0.000757819,0.0021199654,0.000968605,0.000076240955,0.00045037208],"genre_scores_gemma":[0.0024018274,0.9951895,0.000011389275,0.00024530056,0.00034811627,0.0010756787,0.00039818202,0.00015137882,0.00017863557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962819,0.000476569,0.0012476267,0.0008683281,0.0005914615,0.0005341004],"domain_scores_gemma":[0.9972724,0.00019939027,0.00054857763,0.0012176491,0.000050688766,0.00071130093],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016468357,0.0008133648,0.002297704,0.0005736428,0.0001227654,0.000017245518,0.0003887795,0.00013462227,0.001364591],"category_scores_gemma":[0.000048276524,0.0006800631,0.001702663,0.00045549555,0.0003629621,0.00023239126,0.0001315997,0.0003625155,0.000022514316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062733525,0.001766607,0.0002455753,0.025482565,0.00032032278,0.0012802226,0.00005107582,0.000024525327,7.865686e-7,0.00040502465,0.000019935582,0.96413],"study_design_scores_gemma":[0.0012246292,0.0017859836,0.00014704121,0.009113079,0.004157137,0.000006797826,0.000044043405,0.0000746875,2.7888018e-7,0.00013358692,0.9827628,0.0005499212],"about_ca_topic_score_codex":0.0000067855713,"about_ca_topic_score_gemma":0.0000011862611,"teacher_disagreement_score":0.9827429,"about_ca_system_score_codex":0.0014777598,"about_ca_system_score_gemma":0.0021389343,"threshold_uncertainty_score":0.99956506},"labels":[],"label_agreement":null},{"id":"W4293433640","doi":"10.1177/17534666221116997","title":"Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"GlaxoSmithKline","keywords":"Medicine; Asthma; Odds ratio; Exacerbation; Confidence interval; Emergency department; Rate ratio; Internal medicine; Inhaler; Asthma exacerbations","score_opus":0.03776476740931974,"score_gpt":0.3677590197615893,"score_spread":0.3299942523522696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293433640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950215,0.0031457576,0.000043754226,0.00014164714,0.000048612263,0.0013263008,0.0001387288,0.00003573815,0.00009792064],"genre_scores_gemma":[0.9960071,0.00007512169,0.000012467802,0.0031767306,0.000024664954,0.00057836267,0.000045692366,0.00003821551,0.00004163584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975628,0.0005059192,0.0004918061,0.0004172587,0.0006069984,0.0004151915],"domain_scores_gemma":[0.99847543,0.00033437271,0.00021596867,0.00062707684,0.00006192362,0.00028519792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023000606,0.0003445155,0.00051267404,0.00043618178,0.00015372294,0.000019137233,0.00026019925,0.000026073894,0.00016747111],"category_scores_gemma":[0.000054464657,0.00019717976,0.00017258243,0.0009444769,0.0001582321,0.00011796452,0.000052520063,0.00024436341,0.000006711156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008471828,0.0027114283,0.8672341,0.000070144975,0.00008368137,0.0011508279,0.0013400293,0.023079459,0.00013830276,0.000026095728,0.000004006142,0.09569006],"study_design_scores_gemma":[0.005391326,0.019690966,0.959625,0.00019039621,0.00010013872,0.000010569701,0.0030142134,0.00024706873,0.00007357496,0.00006496217,0.011253953,0.00033785333],"about_ca_topic_score_codex":0.00006897174,"about_ca_topic_score_gemma":0.00008011953,"teacher_disagreement_score":0.0953522,"about_ca_system_score_codex":0.00046978102,"about_ca_system_score_gemma":0.00046140535,"threshold_uncertainty_score":0.8040757},"labels":[],"label_agreement":null},{"id":"W4387564307","doi":"10.1177/17534666231202742","title":"All-cause readmission rate and risk factors of 30- and 90-day after discharge in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Pulmonary disease; Intensive care medicine; COPD; Internal medicine; Disease","score_opus":0.06076743744959537,"score_gpt":0.3685336814095517,"score_spread":0.30776624395995633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387564307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007122663,0.9824988,0.000005397662,0.00002442707,0.000021230726,0.008036877,0.0022459729,0.000038441525,0.0000061660294],"genre_scores_gemma":[0.011680146,0.98549557,0.0000062805025,0.000095655065,0.000020535263,0.0021926532,0.00025975727,0.00015510914,0.00009429594],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927816,0.002464968,0.0016636346,0.001536113,0.00088988716,0.0006638033],"domain_scores_gemma":[0.995389,0.00085833773,0.0010950946,0.00133897,0.0001714974,0.0011471126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009548631,0.0011082556,0.0066924496,0.0010534634,0.00008572544,0.00003728433,0.00027492287,0.00016990441,0.00020801763],"category_scores_gemma":[0.0004511596,0.0006855333,0.0008074872,0.0015609873,0.00069523754,0.00047061272,0.00030845514,0.0006959676,0.0000057198436],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005426746,0.00039874265,0.084848166,0.8689515,0.035785697,0.00036226207,0.000053397987,0.000005834627,4.772869e-8,0.000020333448,7.1551784e-7,0.009030612],"study_design_scores_gemma":[0.0009691478,0.00012127913,0.31015575,0.05773059,0.6275596,0.0000013484075,0.000044972043,0.00003785771,6.542829e-8,0.00013268107,0.0025279867,0.000718717],"about_ca_topic_score_codex":0.000013947963,"about_ca_topic_score_gemma":0.000023570527,"teacher_disagreement_score":0.81122094,"about_ca_system_score_codex":0.0005174643,"about_ca_system_score_gemma":0.00070451957,"threshold_uncertainty_score":0.9995596},"labels":[],"label_agreement":null},{"id":"W4390443937","doi":"10.1177/17534666231219630","title":"Prone positioning during CPAP therapy in SARS-CoV-2 pneumonia: a concise clinical review","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Continuous positive airway pressure; Intensive care medicine; Mechanical ventilation; Pneumonia; Intubation; Ventilator-associated pneumonia; ARDS; Respiratory physiology; Ventilation (architecture); Positive airway pressure; Respiratory failure; Coronavirus disease 2019 (COVID-19); Intensive care unit; Anesthesia; Respiratory system; Internal medicine; Lung; Disease","score_opus":0.09652902975398174,"score_gpt":0.43202132585801445,"score_spread":0.3354922961040327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390443937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8705159,0.12591699,0.000027014139,0.0006779899,0.00026737302,0.0018338847,0.000011735903,0.0002415358,0.0005076196],"genre_scores_gemma":[0.9252394,0.055291135,0.000052291656,0.018363431,0.00022133222,0.0005912262,0.000026233209,0.00008877341,0.00012618807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966155,0.0003933976,0.0011394002,0.0007097959,0.0004988572,0.00064300647],"domain_scores_gemma":[0.99856687,0.00012490887,0.00022660718,0.00070889824,0.00008842433,0.00028428526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012549688,0.00035925803,0.0008239173,0.0003662939,0.000098038225,0.00002002955,0.00023595094,0.00012652257,0.00008402796],"category_scores_gemma":[0.00015783771,0.00031735157,0.00025073768,0.0010624602,0.00018345432,0.00040127197,0.0000675946,0.00051200285,0.00017813445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005124685,0.0015653408,0.46060014,0.0045842044,0.00013781649,0.006771029,0.00032818536,0.00006476898,0.08736124,0.0006658694,0.00023784222,0.43255886],"study_design_scores_gemma":[0.014835531,0.0014716547,0.6729311,0.009565031,0.0002234752,0.000024650053,0.0002541018,0.0002340124,0.011532314,0.0023666336,0.28535923,0.0012023232],"about_ca_topic_score_codex":0.0000024192436,"about_ca_topic_score_gemma":0.0000130355675,"teacher_disagreement_score":0.43135655,"about_ca_system_score_codex":0.00013774943,"about_ca_system_score_gemma":0.0004177232,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W4390613200","doi":"10.1177/17534666231221750","title":"Referral rates and barriers to lung transplantation based on pulmonary function criteria in interstitial lung diseases: a retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; DLCO; Interquartile range; Referral; Lung transplantation; Interstitial lung disease; Pulmonary function testing; Retrospective cohort study; Vital capacity; Internal medicine; Cohort; Idiopathic pulmonary fibrosis; Transplantation; Lung; Surgery; Diffusing capacity; Lung function","score_opus":0.019100525857322425,"score_gpt":0.3763069681416257,"score_spread":0.35720644228430326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390613200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802934,0.008985446,0.006975328,0.00027605318,0.0007563531,0.0021661816,0.00016189652,0.00013019046,0.00025517223],"genre_scores_gemma":[0.9971383,0.0003154768,0.000077140234,0.0018496534,0.0001375595,0.00038150078,0.000045819004,0.00003609265,0.000018430308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981361,0.00036053333,0.00035040893,0.0005908994,0.00032338168,0.00023870007],"domain_scores_gemma":[0.9991614,0.00019980983,0.000032593987,0.00021304557,0.000029462108,0.0003636415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039324345,0.00024687717,0.00033622375,0.00046591242,0.00007249791,0.000047981357,0.00006413117,0.0000480712,0.00011675339],"category_scores_gemma":[0.00005205851,0.00021524947,0.00006936221,0.0004278486,0.00007403614,0.00035454571,0.0000078117,0.00022602496,0.0000028344298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010500864,0.00022812205,0.9761912,0.00070901186,0.00004699519,0.0006120885,0.00082963344,0.00032578318,0.00023071564,0.00013551302,0.0000055201663,0.010184508],"study_design_scores_gemma":[0.0018134621,0.0006521964,0.9858854,0.0007236405,0.00047733038,0.0000017240259,0.00053838175,0.00883731,0.000023976165,0.00045742712,0.00036195738,0.00022719847],"about_ca_topic_score_codex":0.000012064954,"about_ca_topic_score_gemma":0.0000704498,"teacher_disagreement_score":0.016844947,"about_ca_system_score_codex":0.00027286014,"about_ca_system_score_gemma":0.00018095014,"threshold_uncertainty_score":0.8777619},"labels":[],"label_agreement":null},{"id":"W4398771069","doi":"10.1177/17534666241255203","title":"Combined medical-interventional approaches for the management of complex fungal balls: a case series as a viable alternative in non-surgical patients","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Health Campus; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Aspergilloma; Cohort; Debulking; Surgery; Multimodal therapy; Antifungal; Antifungal drug; Aspergillosis; Lung; Internal medicine; Cancer; Dermatology","score_opus":0.056743174330412954,"score_gpt":0.36350044424996253,"score_spread":0.30675726991954955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398771069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703489,0.022943135,0.0022490849,0.0004885361,0.00023549041,0.0021665862,0.00013191337,0.000036196445,0.0014001437],"genre_scores_gemma":[0.9985346,0.0003607267,0.0000950576,0.00028310792,0.000049198992,0.00036855618,0.000024021067,0.000019582532,0.00026509943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99823624,0.00010784293,0.00050747284,0.00037570894,0.00051946397,0.0002532849],"domain_scores_gemma":[0.9991343,0.0002960176,0.00007098547,0.00028471855,0.00006411624,0.00014986632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058773515,0.00017911129,0.00031168727,0.00009653557,0.00006106586,0.000017059045,0.0001724929,0.000048197016,0.00028248774],"category_scores_gemma":[0.000042984433,0.00012197516,0.00018845931,0.0002637019,0.00035334865,0.00019863599,0.00006993693,0.00018142507,0.00000641265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03915367,0.0084407,0.3873713,0.015600041,0.0013686233,0.020527372,0.0013407121,0.00094762875,0.000021761194,0.091711424,0.00014263598,0.43337414],"study_design_scores_gemma":[0.040396772,0.006241633,0.66280997,0.01119889,0.0014572861,0.0001651656,0.009723266,0.08793942,0.00022853527,0.057841495,0.12051869,0.0014788564],"about_ca_topic_score_codex":0.000007982728,"about_ca_topic_score_gemma":0.000054762197,"teacher_disagreement_score":0.4318953,"about_ca_system_score_codex":0.000111808426,"about_ca_system_score_gemma":0.00013615227,"threshold_uncertainty_score":0.49740025},"labels":[],"label_agreement":null},{"id":"W4402288418","doi":"10.1177/17534666241275336","title":"The prevalence of asthma and its predictor among patients presenting in Ethiopian public hospitals: systematic review and meta-analysis, 2024","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Asthma; Meta-analysis; Public health; Family medicine; Emergency medicine; Environmental health; Pediatrics; Intensive care medicine; Internal medicine; Nursing","score_opus":0.0540051654020638,"score_gpt":0.3724048435072761,"score_spread":0.3183996781052123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402288418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041823278,0.9925151,0.0000016089775,0.000065233646,0.00008766986,0.0064212973,0.00040621872,0.000036874346,0.000047752914],"genre_scores_gemma":[0.0042629684,0.9926604,0.0000023928867,0.00035629582,0.000035058638,0.001907573,0.000019637275,0.00007855501,0.00067710946],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99383074,0.0016053929,0.0022492225,0.00099862,0.0008049456,0.00051105494],"domain_scores_gemma":[0.99653727,0.00067213224,0.0010843761,0.0010200562,0.0001988371,0.00048731497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014748818,0.00078620994,0.0052504134,0.00068162434,0.000109633715,0.00008815927,0.00047037425,0.00020386219,0.00007243892],"category_scores_gemma":[0.0009831034,0.00042280508,0.0013753225,0.0015964586,0.0004787671,0.00040775267,0.00027310112,0.0006886765,0.0000073028755],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015192466,0.00014852441,0.004451113,0.97624606,0.011479453,0.000053543437,0.000038944287,7.674629e-7,1.41112375e-8,0.00011910258,0.000010343119,0.0074369484],"study_design_scores_gemma":[0.00039145342,0.00015396156,0.0051248446,0.11464176,0.78735054,0.0000021266605,0.000048501603,0.00003462916,8.5699476e-8,0.00010363854,0.09156476,0.00058366795],"about_ca_topic_score_codex":0.0000010373954,"about_ca_topic_score_gemma":0.000014492555,"teacher_disagreement_score":0.8616043,"about_ca_system_score_codex":0.00010042237,"about_ca_system_score_gemma":0.0004643784,"threshold_uncertainty_score":0.9998224},"labels":[],"label_agreement":null},{"id":"W4404192740","doi":"10.1177/17534666241287307","title":"Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Respiratory Disease","topic":"Nematode management and characterization studies","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Daiichi Sankyo Europe; Genentech; United Therapeutics Corporation; Veracyte; Daewoong Pharmaceutical Company; Galecto; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Biogen; Celgene; FibroGen; Pulmonary Fibrosis Foundation","keywords":"Medicine; Idiopathic pulmonary fibrosis; Plain language; Intensive care medicine; Internal medicine; Lung; Linguistics","score_opus":0.013896700900590399,"score_gpt":0.25722135746876024,"score_spread":0.24332465656816984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404192740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98403883,0.014701257,0.0000072784806,0.00035262303,0.000050990082,0.00051280466,0.000037050275,0.000028766108,0.00027041227],"genre_scores_gemma":[0.999436,0.00021125475,0.0000017075407,0.00012755777,0.000032544252,0.00011307977,0.000009793595,0.0000021681901,0.00006589748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988924,0.0001868968,0.0003090663,0.00023572709,0.0002439388,0.00013195418],"domain_scores_gemma":[0.9996189,0.00008632348,0.00011369127,0.000114831564,0.00003535586,0.00003088801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028931626,0.00012509347,0.00019435651,0.000052450632,0.000049396425,0.000023832119,0.0002538248,0.000023126344,0.000034252756],"category_scores_gemma":[0.000021251806,0.000045131237,0.000052270574,0.0010148699,0.00009296059,0.00026746388,0.000088813395,0.000104349834,0.0000016737969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032038637,0.0006390888,0.84687054,0.0002782331,0.000026913864,0.000010926994,0.001380141,0.00003976663,0.013303577,0.0006326132,0.000008305487,0.1364895],"study_design_scores_gemma":[0.0001699483,0.0001593519,0.99051267,0.0003925018,0.000030814932,1.5445549e-7,0.0052138953,0.0001176042,0.0002481425,0.00033421317,0.002697361,0.00012333445],"about_ca_topic_score_codex":0.000034607518,"about_ca_topic_score_gemma":0.0013007692,"teacher_disagreement_score":0.14364213,"about_ca_system_score_codex":0.000023950044,"about_ca_system_score_gemma":0.000019548123,"threshold_uncertainty_score":0.18403985},"labels":[],"label_agreement":null},{"id":"W4406431527","doi":"10.1177/17534666241308405","title":"Sleep and breathing in children with Joubert syndrome and a review of other rare congenital hindbrain malformations","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Medicine; Joubert syndrome; Polysomnography; Cohort; Pediatrics; Obstructive sleep apnea; Sleep apnea; Holoprosencephaly; Apnea; Internal medicine; Genetics","score_opus":0.010750402135479079,"score_gpt":0.29967304316340315,"score_spread":0.2889226410279241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406431527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033393407,0.9949292,0.000044942375,0.000012827524,0.000017515466,0.0011396661,0.00039647284,0.0000061186197,0.00011394633],"genre_scores_gemma":[0.0033111416,0.99522763,0.000062492814,0.0009522199,0.000018093215,0.00023331463,0.0001273837,0.000030370573,0.00003734806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851257,0.0002380832,0.0004961859,0.0004174184,0.00012867752,0.0002070538],"domain_scores_gemma":[0.9991831,0.0000389468,0.00021226387,0.0003765766,0.000033171487,0.00015590385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017071546,0.0003405695,0.00076813664,0.00015758302,0.000036471163,0.000012990823,0.0001840811,0.00011574717,0.000014430195],"category_scores_gemma":[0.000068311994,0.00026786764,0.000108686334,0.00021233023,0.00019849912,0.000017947461,0.00009896592,0.00013255092,6.9670705e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009814735,0.00018045655,0.010678741,0.09545615,0.0003267922,0.000034611774,0.000030211038,0.0000068252757,0.0000051496395,0.000058642327,0.00002053444,0.8931037],"study_design_scores_gemma":[0.002313787,0.00042304708,0.010080079,0.12839623,0.0021893694,0.00014167011,0.00005755911,0.0000067447654,0.000009522229,0.00021237209,0.8548869,0.001282713],"about_ca_topic_score_codex":0.0000029944579,"about_ca_topic_score_gemma":0.000007359612,"teacher_disagreement_score":0.891821,"about_ca_system_score_codex":0.000018971985,"about_ca_system_score_gemma":0.00039152478,"threshold_uncertainty_score":0.99997735},"labels":[],"label_agreement":null},{"id":"W4409767527","doi":"10.1177/17534666251333965","title":"Asthma and the risk of cardiovascular diseases and mortality: a meta-analysis of cohort studies","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Asthma; Relative risk; Meta-analysis; Internal medicine; Myocardial infarction; Angina; Confidence interval; Cohort study; Cochrane Library; Epidemiology; Observational study; Heart failure","score_opus":0.07746107039519876,"score_gpt":0.4023995718185983,"score_spread":0.32493850142339953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409767527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009965101,0.9954252,0.000040911927,0.000010233391,0.000058053185,0.0022268328,0.0011662,0.000023453078,0.000052609696],"genre_scores_gemma":[0.0030242705,0.9958748,0.000010223205,0.0001988481,0.00004536924,0.0007418362,0.000027301518,0.000037489895,0.000039811956],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99466443,0.0020276997,0.0014440474,0.0008279877,0.0007519571,0.0002838652],"domain_scores_gemma":[0.9952576,0.0017965443,0.0008994501,0.0015388256,0.0002256279,0.00028191184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012329011,0.0006880707,0.009709882,0.00080302503,0.00010679896,0.000013925867,0.00025917406,0.00013610518,0.000030601354],"category_scores_gemma":[0.00068517006,0.00036274397,0.0058272765,0.001452646,0.0022963309,0.00012136579,0.00021699387,0.00030563038,4.4743345e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003313208,0.00020406,0.012411697,0.035699643,0.58558226,0.00005666065,0.00005133865,0.00021179103,1.6287363e-8,0.0003179904,0.0000032100409,0.36513],"study_design_scores_gemma":[0.0008651492,0.000057142268,0.006587105,0.0013215077,0.7335043,6.074835e-7,0.00011950522,0.000015352603,1.3192117e-7,0.00029507824,0.25700533,0.00022882479],"about_ca_topic_score_codex":0.00001356642,"about_ca_topic_score_gemma":0.000009252136,"teacher_disagreement_score":0.36490119,"about_ca_system_score_codex":0.000049447768,"about_ca_system_score_gemma":0.00060579303,"threshold_uncertainty_score":0.99988246},"labels":[],"label_agreement":null}]}